Ex vivo tumor cultures and patient-derived xenograft models demonstrated that human IL-7 upregulated pro-inflammatory cytokines and activated infiltrating CD4+ and CD8+ T cells in a dose-dependent manner [60]. The gene discussed is IL7; the disease is neoplasm.